Autobio Diagnostics' (SHA:603658) unit, Autobio Laboratory Instruments (Zhengzhou), renewed its medical device manufacturing license after changing its manufacturing scope, according to a Shanghai bourse filing on Thursday.
The new manufacturing scope included in vitro diagnostic software, immunoassay equipment, microbiological analysis kits, and other similar equipment.
The Henan Medical Products Administration issued the renewed license, which is valid until May 20, 2031.